Novel Polymorphisms Associated With Tacrolimus Trough Concentrations: Results From a Multicenter Kidney Transplant Consortium
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: The CYP4503A5*1 genotype is associated with lower tacrolimus concentrations. Although its effect is important, it incompletely explains the variability in tacrolimus concentrations and has a relatively low minor allele frequency in whites relative to African Americans (AA). METHODS: We studied clinical and recipient genetic correlates of dose-normalized tacrolimus troughs (n=12,277) in the first 6 months posttransplant using a customized single-nucleotide polymorphism chip with 2722 variants in a large, ethnically diverse (144 AA and 551 non-AA) adult kidney transplant population through a seven-center consortium. RESULTS: During the 6-month study, AAs had consistently lower median (interquartile range) troughs than non-AAs, 6.2 (4.4-8.4) ng/mL vs. 8.3 (6.4-10.4) ng/mL (P<0.0001), despite 60% higher daily doses, 8 (5-10) mg vs. 5 (4-7) mg (P<0.0001). The median tacrolimus trough concentration in week 1 posttransplant was particularly low in AAs (2.1 [1.2-3.5] ng/mL) compared with non-AAs (5.0 [3.1-8.2] ng/mL) (P<0.0001), despite similar initial doses. In single-variant analysis, CYP3A5*3 (rs776746) was the top variant (P=2.4×10) associated with troughs. After adjustment for CYP3A5*3, clinical factors and race, 35 additional variants were identified (P<0.01, not significant at false discovery rate 20%). In the final multivariant, regression models beginning with these variants and clinical factors, seven variants were identified in the non-AA and seven variants in the AA group towards the first trough concentrations. Rs776746 (CYP3A5), rs2239393 (COMT) and diabetes were the only factors common in both populations. CONCLUSION: We identified variants beyond CYP3A5*3, which may further explain pharmacokinetic variability of tacrolimus and demonstrated that important variants differ by race.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Li, Y. R., & Keating, B. J. (2014) · Genome Medicine · doi:10.1186/s13073-014-0091-5 · Cited by 214
“pharmacogenomics response [16-18] and of other phenotypic traits [19].”
BackgroundGut Microbiota and Tacrolimus Dosing in Kidney Transplantation
Lee, J. R., Muthukumar, T., Dadhania, D., Taur, Y., Jenq, R. R., Toussaint, N. C., Ling, L., Pamer, E., & Suthanthiran, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122399 · Cited by 211
Tang, J., Liu, R., Zhang, Y.-L., Liu, M.-Z., Hu, Y.-F., Shao, M.-J., Zhu, L.-J., Xin, H.-W., Feng, G.-W., Shang, W.-J., et al. (2017) · Scientific Reports · doi:10.1038/srep42192 · Cited by 154
Gaber, A. O., Alloway, R. R., Bodziak, K., Kaplan, B., & Bunnapradist, S. (2013) · Transplantation · doi:10.1097/tp.0b013e3182962cc1 · Cited by 100
Trofe-Clark, J., Brennan, D. C., West-Thielke, P., Milone, M. C., Lim, M. A., Neubauer, R., Nigro, V., & Bloom, R. D. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.07.018 · Cited by 93
“Pharmacogenetic studies of tacrolimus in African Americans (such as DeKAF) have been limited by: (1) tacrolimus assays being performed at individual centers rather than a centralized laboratory, (2) lack of standardized tacrolimus dosing,(22) and (3) measurement of trough concentrations rather than steady-state pharma…”
BackgroundDarakjian, L., Deodhar, M., Turgeon, J., & Michaud, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094967 · Cited by 53
Metadata
- Authors
- Jacobson, P. A., Oetting, W. S., Brearley, A. M., Leduc, R., Guan, W., Schladt, D., Matas, A. J., Lamba, V., Julian, B. A., Mannon, R. B., & Israni, A.
- Venue
- Transplantation
- Published
- 2011-02-15
- Volume
- 91
- Issue
- 3
- Pages
- 300-308
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2121987020
- Cited by
- 170
- References
- 0
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.